The way forward in bioprocess liquid and buffer outsourcing
The way forward in bioprocess liquid and buffer outsourcing
Explore custom formulation development to help streamline processes
Biomanufacturing has evolved from classical protein biologicals and vaccines to a diverse number of current products and therapeutics—such as mRNA vaccines, medical devices, and tissue, cell, and gene therapies. Approaches to buffer preparation has become more important of late due to this increase in product offerings, increases in volumetric productivity upstream, and developments in bioprocessing materials, processes, and facilities. Labor-intensive and inflexible buffer supply methods can impose financial and operational stress, as well as processing bottlenecks. We can help you streamline processes so you can focus on developing therapies to help meet growing population needs.
Expanding capacity and capabilities to help meet evolving biomanufacturing needs
Opening in summer of 2023, this 70% capacity expansion supports manufacturing of buffers and process liquids used in bioprocessing. The expansion helps meet the increasing global demand for more complex molecule development and increases the site’s capacity to produce critical raw materials used in the development and manufacturing of biologic therapies.
Video Player is loading.
Current Time 0:00
/
Duration 0:26
Loaded: 0%
0:00
Stream Type LIVE
Remaining Time -0:26
1x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
en (Main), selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
The way forward in buffer manufacturing
Expansion includes manufacturing Thermo Fisher Scientific's process liquids and buffers with capability for large volume liquids and cell culture media to help the development and commercial manufacturing of critical medicines.
Video Player is loading.
Current Time 0:00
/
Duration 0:23
Loaded: 0%
0:00
Stream Type LIVE
Remaining Time -0:23
1x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
en (Main), selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
The way forward with quality management
Quality you can rely on. We're focused on meeting your current and future requirements for outsourcing bulk liquids with the utmost commitment to quality and compliance with cGMP standards.
Video Player is loading.
Current Time 0:00
/
Duration 0:22
Loaded: 0%
0:00
Stream Type LIVE
Remaining Time -0:22
1x
Chapters
descriptions off, selected
captions settings, opens captions settings dialog
captions off, selected
en (Main), selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
The way forward with supply assurance
Benefit from our global network of cGMP chemical raw materials from redundant supply base to help meet demand.
Our Process Walk program is designed to drive process optimization and reduce cost. View examples across the bioprocessing workflow where technical engagement helped to drive performance through collaboration.
